These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 12235823

  • 1. [A study on pathomechanisms of paraneoplastic neurological syndrome].
    Tanaka K.
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1150-2. PubMed ID: 12235823
    [Abstract] [Full Text] [Related]

  • 2. [Pathogenesis of paraneoplastic neurological syndromes].
    Tanaka K.
    Brain Nerve; 2010 Apr; 62(4):309-18. PubMed ID: 20420170
    [Abstract] [Full Text] [Related]

  • 3. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Idezuka J, Tsuji S.
    Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
    [Abstract] [Full Text] [Related]

  • 4. [A candidate peptide reacting with cytotoxic T cells in paraneoplastic cerebellar degeneration with anti-Yo antibody].
    Tanaka M, Tanaka K.
    Rinsho Shinkeigaku; 1999 Jun; 39(6):603-5. PubMed ID: 10502981
    [Abstract] [Full Text] [Related]

  • 5. The spectrum of antineuronal autoantibodies in a series of neurological patients.
    Vianello M, Vitaliani R, Pezzani R, Nicolao P, Betterle C, Keir G, Thompson EJ, Tavolato B, Scaravilli F, Giometto B.
    J Neurol Sci; 2004 May 15; 220(1-2):29-36. PubMed ID: 15140602
    [Abstract] [Full Text] [Related]

  • 6. [Paraneoplastic motor neuron disease].
    Sakakibara R.
    Ryoikibetsu Shokogun Shirizu; 2000 May 15; (29 Pt 4):355-9. PubMed ID: 11031968
    [No Abstract] [Full Text] [Related]

  • 7. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul 15; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 8. [Paraneoplastic cerebellar degeneration].
    Sakai K.
    Brain Nerve; 2010 Apr 15; 62(4):357-64. PubMed ID: 20420175
    [Abstract] [Full Text] [Related]

  • 9. Hu antigen specificities of ANNA-I autoantibodies in paraneoplastic neurological disease.
    King PH, Redden D, Palmgren JS, Nabors LB, Lennon VA.
    J Autoimmun; 1999 Dec 15; 13(4):435-43. PubMed ID: 10585760
    [Abstract] [Full Text] [Related]

  • 10. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
    Sutton IJ, Steele J, Savage CO, Winer JB, Young LS.
    J Neuroimmunol; 2004 May 15; 150(1-2):98-106. PubMed ID: 15081253
    [Abstract] [Full Text] [Related]

  • 11. Autoantibodies against the Hel-N1 RNA-binding protein among patients with lung carcinoma: an association with type I anti-neuronal nuclear antibodies.
    Dropcho EJ, King PH.
    Ann Neurol; 1994 Aug 15; 36(2):200-5. PubMed ID: 8053656
    [Abstract] [Full Text] [Related]

  • 12. [Paraneoplastic neurological autoimmune diseases].
    Voltz R.
    Dtsch Med Wochenschr; 2004 Aug 13; 129(33):1743-6. PubMed ID: 15295685
    [No Abstract] [Full Text] [Related]

  • 13. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A, Stourac P, Rusina R, Sejdová M, Velenská Z.
    Nervenarzt; 2002 Oct 13; 73(10):995-8. PubMed ID: 12376889
    [Abstract] [Full Text] [Related]

  • 14. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
    Sillevis Smitt P, Grefkens J, de Leeuw B, van den Bent M, van Putten W, Hooijkaas H, Vecht C.
    J Neurol; 2002 Jun 13; 249(6):745-53. PubMed ID: 12111309
    [Abstract] [Full Text] [Related]

  • 15. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
    Tanaka K, Tanaka M, Onodera O, Igarashi S, Tsuji S.
    No To Shinkei; 1994 Jan 13; 46(1):47-51. PubMed ID: 8136199
    [Abstract] [Full Text] [Related]

  • 16. No evidence for circulating HuD-specific CD8+ T cells in patients with paraneoplastic neurological syndromes and Hu antibodies.
    de Beukelaar JW, Verjans GM, van Norden Y, Milikan JC, Kraan J, Hooijkaas H, Sintnicolaas K, Gratama JW, Sillevis Smitt PA.
    Cancer Immunol Immunother; 2007 Sep 13; 56(9):1501-6. PubMed ID: 17597332
    [Abstract] [Full Text] [Related]

  • 17. Paraneoplastic antibodies detected by isoelectric focusing of cerebrospinal fluid and serum.
    Storstein A, Monstad SE, Honnorat J, Vedeler CA.
    J Neuroimmunol; 2004 Oct 13; 155(1-2):150-4. PubMed ID: 15342206
    [Abstract] [Full Text] [Related]

  • 18. [Paraneoplastic encephalomyelitis/sensory neuropathy].
    Tanaka M, Tanaka K.
    Ryoikibetsu Shokogun Shirizu; 2000 Oct 13; (31):68-72. PubMed ID: 11269191
    [No Abstract] [Full Text] [Related]

  • 19. Anti-Hu antibody neuropathy: a clinical, electrophysiological, and pathological study.
    Oh SJ, Gürtekin Y, Dropcho EJ, King P, Claussen GC.
    Clin Neurophysiol; 2005 Jan 13; 116(1):28-34. PubMed ID: 15589180
    [Abstract] [Full Text] [Related]

  • 20. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
    Uchuya M, Graus F, Vega F, Reñé R, Delattre JY.
    J Neurol Neurosurg Psychiatry; 1996 Apr 13; 60(4):388-92. PubMed ID: 8774401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.